You may already know a lot of the names that are considered leaders of the diabetes technology industry. The likes of Abbott and Dexcom are leaders in the continuous glucose monitor (CGM) space. MiniMed, Insulet and Tandem Diabetes Care are a few of the companies with a significant share in the automated insulin delivery (AID) […]
Patient Monitoring
The 10 largest diabetes tech companies in the world in 2026
Over the last year, a lot has changed in the diabetes technology space. Does that ring true for the rankings of the space’s largest companies? Within the last 12 months, we’ve seen one of the industry’s biggest players separate from its parent company. We’ve also seen significant regulatory milestones, product launches and unveilings of next-generation […]
Diabetes Technology Innovations Special Report — 2026
Last year, MassDevice and Drug Delivery Business News rolled out the first edition of their Diabetes Technology Innovations Special Report. Now, we have the second edition available for free download, providing an in-depth overview of where the diabetes industry currently stands after another year of innovation and growth. The diabetes tech industry delivers some of the most advanced combinations of […]
Dexcom Q2 results beat expectations, lead to increased sales outlook
Dexcom (Nasdaq:DXCM) today reported second-quarter results that came in ahead of the consensus Wall Street forecast. Shares of DXCM rose 2% to $76.02 apiece after the market closed today. The San Diego-based continuous glucose monitor (CGM) maker reported profits of $249.1 million. That equals 64¢ per share on sales of $1.31 billion for the three […]
FDA selects Dexcom for new digital health device pilot
The FDA announced today that it selected Dexcom (Nasdaq:DXCM) as the first manufacturer for a new digital health pilot. Dexcom joins the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot. It intends to provide a device for use in delivering care expected to be covered by the Centers for Medicare & Medicaid Services […]
Trinity Biotech inks partnership to pair CGM+ with drug delivery system
Trinity Biotech (Nasdaq:TRIB) announced today that it entered into a strategic collaboration with drug delivery tech developer Latch Medical. Latch Medical develops Pharma Latch, an intradermal drug delivery platform. The hollow, microneedle-based intradermal drug delivery technology is designed to enable precise, reliable and repeatable delivery of injectable therapies into the skin. The company developed it […]
MiniMed says Flex insulin pump is now available through Medicare
MiniMed (Nasdaq:MMED) announced today that Medicare and Medicare Advantage beneficiaries now have access to its Flex insulin pump. Beneficiaries can now access the MiniMed Flex and its latest sensor portfolio, which currently includes the Simplera Sync sensor, a disposable, all-in-one sensor with easy two-step insertion. The company plans to roll it out with the Instinct sensor, made by […]
Abbott to launch Libre Duo dual sensor internationally in the fall, expects future reimbursement catalysts
Abbott (NYSE:ABT) plans to launch its Libre Duo dual glucose-ketone sensor internationally in the fall, company leadership said today. CEO and Chair Robert B. Ford said on the company’s second-quarter earnings call that Abbott expects the launch in a few months, following CE mark approval for the multi-analyte sensor in May. Branded as Libre Duo […]
Glucotrack combines with Lōkahi Therapeutics to become CBGM subsidiary
Glucotrack (Nasdaq:GCTK) announced that it completed a strategic business combination with Lōkahi Therapeutics. The companies structured the combination so that Lōkahi becomes the operating and controlling business of the combined company. It now leverages Glucotrack’s continuous blood glucose monitoring (CBGM) business as a wholly owned subsidiary. According to a news release, the combined organization integrates […]
Dexcom picks up Health Canada nod for G7 15 Day
Dexcom (Nasdaq:DXCM) announced today that Health Canada authorized its G7 15 Day continuous glucose monitor (CGM) system. Health Canada approval covers people 18 years and older living with diabetes. It brings the G7 15 Day, its longest-lasting wearable sensor, to Canada, with the system already possessing FDA clearance. G7 15 Day delivers several features of […]
